TTR and autonomic neuropathy: To date, more than one hundred amyloidogenic TTR mutations have been identified leading to a variety of clinical manifestations ranging from peripheral and autonomic neuropathy, to cardiomyopathy, ophthalmopathy and vitreous opacities and carpal tunnel syndrome, among others [12,13,14,15,16,17,18,19,20,21].